La recherche

Synposes of research studies aimed at tackling key global health challenges to address inequities and disparities in health.

In Canada, chlamydia is the most commonly reported STBBI.

HIV and HCV in Mother and Child Dr. Hugo Soudeyns, Professor at Université de Montréal and researcher at CHU Sainte-Justine, has been involved with HIV research since the early years of its emergence. He has seen a considerable amount change over this time, from knowing little about the virus at… Read more of the article: Researcher Profile: Dr. Hugo Soudeyns

AIDS: Existing Treatments Are Not Effective Enough

Interview transcript with Dr. Marc Ouellette, Scientific Director of the CIHR Institute of Infection and Immunity who discusses how Canada is contributing to the global effort to end HIV/AIDS.

Ongoing HIV transmission remains an issue of concern in Canada. The Agency estimates that 2,570 new infections (range between 1,940 and 3,200) occurred in Canada in 2014. This estimate is slightly lower than the estimate for 2011 (2,800; range between 2,100 and 3,500) (Table 1, Figure 1). The estimated incidence… Read more of the article: Summary: Estimates of HIV Incidence, Prevalence and Proportion Undiagnosed in Canada

Routine surveillance of HIV among pregnant mothers and infants in Canada.

Sharing research on the effects of HIV-Associated Neurocognitive Disorders (HAND). Francisco Ibanez-Carrasco interviews an esteemed panel of researchers about recent studies of HIV-Associated Neurocognitive Disorder

CTAC Policy Researcher, Adam Cook, discusses the prevalence, cure and accessibility of treatment for people living with hepatitis C in Canada.

Polypharmacy is defined as the concurrent use of five or more medications. This document addresses the issue, risks, and tools for mitigating the effects of polypharmacy among older adults living with HIV